Home > PJ (current issue) > Articles
|
This article |
Is extemporaneous dispensing really in the best interest of patients? |
|
In this article Ryan Donnelly, Martin McNally and Johanne Barry examine extemporaneous dispensing in British community pharmacies and call for a UK-wide study to assess the quality of the products prepared and see whether the activity may be actually detrimental to patient safety |
SUMMARY Extemporaneous dispensing is the process of compounding ingredients to prepare a medicine for an individual patient. In extemporaneous dispensing, a pharmacist prepares an unlicensed medicine for supply in accordance with a prescription. This activity may need to be carried out where no
licensed product is available or where the formulation of the licensed
product is not suitable. In many instances, extemporaneous dispensing
has involved the preparation of a paediatric medicine in the form of
an oral liquid from an adult medicine. The recent involvement of community pharmacists in prescribing and medicines management and repeat dispensing initiatives, allied to ever more time spent on health promotional activities means that the profession is currently more patient-focused than product-oriented. Despite this, a significant number of extemporaneous products are still dispensed in the UK every year. For example, in 2001, 0.05 per cent
of all prescriptions written in England were for unlicensed medicines,
including
those prepared extemporaneously. Given that around 587 million prescriptions
were dispensed in England that year, this still represents a significant
number of products, indicating a continued need for this service
in the community. This, linked with an appreciation of patient need, in terms of delivery route (oral, rectal or topical), meant the pharmacist was the only professional capable of delivering a unique medicine for a specific patient. Full text article PDF (80K) |